BACKGROUND: Thermal stability signatures of complex molecular interactions in biological fluids can be measured using differential scanning calorimetry (DSC). Evaluating the thermal stability of plasma proteomes offers a method of producing a diseasespecific "signature" (thermogram) in neoplastic and autoimmune diseases. OBJECTIVE: The authors describe the use of DSC with human brain tumor tissue to create unique thermograms for correlation with histological tumor classification. METHODS: Primary brain tumors were classified according to the World Health Organization classification. Tumor samples were digested and assayed by a DSC calorimeter. Experimental thermograms were background subtracted and normalized to the total area of transitions to exclude concentration effects. The resulting thermograms were analyzed by applying 2-state, scaled, Gaussian distributions. RESULTS: Differences in glioma-specific signatures are described by using calculated parameters at transitions that are characterized, in the equilibrium approximation, by a melting temperature (T m ), an apparent enthalpy change (DH), and a scaling factor related to the relative abundance of the materials denatured in the transition (A w ). Thermogram signatures of glioblastoma multiforme and low-grade astrocytomas were differentiated by calculated values of A w3 and T m4, those of glioblastoma multiforme and oligodendrogliomas were differentiated by A w2 , DH 2 , DH 4 , and T m4 , and those of lowgrade astrocytomas and oligodendroglioma were differentiated by A w4 . CONCLUSION: Our preliminary results suggest that solid brain tumors exhibit specific thermogram profiles that are distinguishable among glioma grades. We anticipate that our results will form the conceptual base of a novel diagnostic assay based on tissue thermograms as a complement to currently used histological analysis.
G lioblastoma multiforme (GBM) is the most common and most malignant brain tumor in humans, with a survival rate of only 0 to 5% at 5 years after presentation, despite aggressive therapies including surgery, radiation, and chemotherapy. 1, 2 Preoperative magnetic resonance imaging is reasonably good at distinguishing low-grade astrocytomas from their higher grade counterparts or even differentiating metastatic tumors from primary brain tumors; however, there are still many instances in which the intraoperative findings deviate from the preoperative imaging diagnosis. 1 Because treatment regimens differ greatly among tumor types and grading classifications, in most cases, a histological diagnosis is considered the standard of care before embarking on a given therapy 3 ; however, the selection of treatment is confounded by the fact that some patients survive several years, whereas others with histologically identical GBMs survive only weeks. As such, tumor histology is a poor predictor of outcome and survival on an individual basis. efficacious targeted therapies and to better assess the potential response of a tumor to therapy.
Currently, the tumor classifications that have the most impact on characterization are histological grade, immunohistological markers, mitotic index, evidence of necrosis, and the magnetic resonance imaging enhancement pattern. 1, 3, 4 Past and current research and treatments have focused heavily on these pathological hallmarks that are all too often not predictive of tumor aggressiveness or response to a given therapy. 3 This report is a proof-of-principle study based on the hypothesis that the supramolecular structures of various cell types differ in composition and interactions caused by different cell-specific expression patterns. Because tumors are heterogeneous structures from the point of view of cellular architecture, we suggest that relative populations of different cells change with the tumor progression. These differences may be quantitatively evaluated by differential scanning calorimetry (DSC), which provides a characteristic melting profile (thermogram) for macromolecules and their complexes. DSC is a well-established method to characterize polymers, in which heat-induced structural changes are accompanied by endothermic (or exothermic) phase transitions that are observed as changes in excess heat capacity of the sample as a function of temperature (thermogram). Briefly, the sample and the reference (usually a buffer solution) are placed in calorimetric cells and are heated with linear temperature ramp under equilibrium adiabatic conditions. Biopolymer phase transitions are usually endothermic and hence cause an imbalance of temperature between the reference and the sample cells. The amount of additional power that needs to be supplied to the sample cell to reestablish temperature balance is the measure of the excess heat capacity of the melting transition.
In recent years, several reports have demonstrated the potential diagnostic utility of thermograms of biological fluids, in particular blood plasma 5, 6 and synovial fluid. 7 We reported the results of a preliminary study that demonstrated GBM-specific shifts in the thermograms of cerebrospinal fluid. 8 Here we evaluate whether the thermograms of solid brain tumors can be used as diseasespecific signature identifiers of brain tumor type and grade; if so, the possibility exists that these thermograms could be used to predict tumor aggressiveness and make rational decisions for postoperative therapeutic strategy.
PATIENTS AND METHODS

Study Participants
Tumors were collected under an institutional review board-approved protocol. Tumors selected for this study were newly diagnosed, de novo primary brain tumors in adults. The resected tumors represented tumor tissue only without any normal surrounding tissue. The "normal" patient samples were collected from epilepsy patients undergoing resection of nonneoplastic seizure focus collected under the same institutional review board protocol. Patient information was collected with respect to age, sex, and location of the tumor. Tumors were classified according to the World Health Organization (WHO) classification of primary brain tumors.
Sample Processing
Tumor samples (500-1000 mg by mass) were stored in liquid nitrogen immediately after resection. For DSC experiments, the samples were thawed in a water bath (37°C, 3 minutes) and minced with scissors. They were incubated overnight (16 hours) at 37°C in 0.2 mg/mL collagenase (Sigma-Aldrich, St. Louis, Missouri) and 0.1 mg/mL DNAse (Sigma-Aldrich) in phosphate-buffered saline (PBS) in a total volume of 5 mL. The digests were pushed through 100-mesh stainless steel screens, washed in a total volume of 70 mL of PBS, and centrifuged 3 times at 1000 rpm for 10 minutes each. The resulting pellet was resuspended in PBS to a final volume of 1 mL.
Microcalorimetry
All of the blinded samples (designated only by numbers) were assayed in a Nano II DSC calorimeter (TA Instruments, Lindon, Utah) within 24 hours after preparation. Sample volume was kept at 580 mL, with the reference cell filled with the same volume of PBS. The temperature ramp rate was 1.5°C/min, and the temperature interval was 20°to 110°C. Experimental thermograms were background subtracted using a NanoAnalyze resident fourth-order spline fit and normalized to the total area of transitions to exclude concentration effects. The resulting thermograms were analyzed by applying 2-state, scaled, Gaussian distributions with the NanoAnalyze version 2.2.0 (TA Instruments) software package. The samples were run in duplicate/triplicate (when possible), and the results were averaged among the runs to increase statistical robustness. Statistical analyses were performed with single-factor ANOVA (Microsoft Excel) with P , .05 considered significant.
RESULTS
Patient Characteristics
Tumors from 42 patients were included. Twenty-four tumors were scored as WHO grade III or IV, including 22 GBMs. Eighteen tumors were scored as WHO grade II tumors, including 8 low-grade astrocytomas, 1 mixed oligoastrocytoma, and 9 oligodendrogliomas. The age range of patients was 24 to 71 years of age (mean, 48 years); the mean ages of those with WHO grade III/IV and WHO grade II tumors were 54 and 45 years, respectively. Seventeen patients were male and 25 were female. Tumor location was evenly divided between the left and right sides, with most tumors coming from the frontal or temporal lobes. Tumors were collected between 2001 and 2011 and were stored in liquid nitrogen before DSC assay processing.
Microcalorimetry of Normal Brain
To evaluate capabilities of the microcalorimetry with respect to analyzing brain tissue samples and to assess sensitivity and reproducibility of the thermograms, we started with an analysis of normal brain tissue (temporal lobe, 2 g by mass). The sample was prepared as described above and divided into 8 aliquots (total volume 5 mL). Thermograms (plots of heat capacity vs temperature) of normal brain tissue samples exhibited several prominent transitions ( Figure 1) . Each of the peaks on the curves in Figure 1 indicates a separate group of transitions caused by thermal disruption of cellular structures (eg, melting of membranes and denaturation of proteins and nucleic acids). Qualitative examination of these thermograms of normal brain tissue reveals that there are 3 areas of temperatures where denaturation occurs, namely, at 55°to 65°C, at 73°to 77°C, and at 87°to 94°C. The transition at the highest temperature is reversible (data not shown) and thus is probably caused by unfolding/melting of nucleic acids (double-stranded DNA and folded RNA). The structures disrupted in the other transitions are at present unknown. The transitions can be characterized, in the equilibrium approximation, by a melting temperature, an apparent enthalpy change, and a scaling factor that is related to the relative abundance of the materials denatured in the transition. In other words, the transition peaks are described by their position on the temperature scale, their amplitudes, and their shapes.
To quantify the information from the transitions, each thermogram was simultaneously fitted to 4 independent Gaussian distribution curves according to the following equation:
, T is the temperature in Kelvin, R is the gas constant, T m is the temperature of the transition peak maximum, DH is the enthalpy change for the transition with an assumed molecular weight, A w is a weighting factor proportional to the amount of material in the transition, and C p is excess heat capacity (NanoAnalyze version 2.2.0, TA Instruments). Figure 2 shows the result of the fitting procedure for normal brain tissue. The goodness of fit (ie, the differences between the experimental points and fitted curves) is shown in the lower graph. Four transition approximations were used because approximation with 3 apparent transitions resulted in inadequate fit, whereas 5 transition approximations did not significantly improve the goodness of fit (results not shown). The fitting procedure adopted for the analysis produces a set of 12 parameters: A w , T m , and DH for each of the 4 transitions.
Because these parameters quantitatively capture all of the characteristics of the transitions, further analysis of thermograms can be done using only this parameter set. To evaluate reproducibility of the experimental procedure, we assessed SDs of 6 replicates of the normal brain tissue (2 samples were discarded because of air bubbles introduced during loading of the cells) ( Table 1 ).
These results demonstrate high reproducibility of the thermograms with respect to melting temperatures and apparent enthalpies of transitions (SDs ,10%), whereas scaling factors are more dispersed (SDs = 10%-30%).
Tumor Tissue Thermograms
Using the results of the normal brain tissue analysis, we pursued the main task of the project; that is, we studied whether different tumor grades and types can be differentiated based on their signature thermograms. Figure 3 illustrates the thermogram signatures of 3 glioma groups: oligodendrogliomas, low-grade astrocytomas, and GBMs. Differences in glioma-specific signatures are observed but better seen after fitting the curves using techniques described for Figure 4 ). The signatures of GBM and low-grade astrocytomas were differentiated by A w3 and T m4 ; those of GBM and oligodendrogliomas were differentiated by A w2 , DH 2 , DH 4 , and T m4 , those of low-grade astrocytomas and oligodendroglioma were differentiated by A w4 . We found no differences in T m (except the highest temperature transition T m4 , which differentiates GBM) between tumor histologies. The full results of statistical analysis are provided (see Table, Supplemental Content 2, which includes numerical results of ANOVA of the fitting parameters of thermograms using a 4-transition approximation; each page is a separate parameter of a transition; yellow denotes statistically significant value [P , .05] and green denotes nonsignificant P value; http://links.lww.com/NEU/A537). We propose that these differences could be used to identify glioma types and grades. This result suggests an opportunity for further subgrouping of the thermogram signatures and possibly identifying signatures correlated with different responses to subsequent therapeutic protocols.
DISCUSSION
Our study is motivated by the need for new technologies and approaches to characterize brain tumors. Although the advances in genomics and proteomics of brain tumors made during the past 15 years are impressive, it is becoming evident that the goal of finding tumor-specific molecular biomarkers is not easily achieved.
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The standard method currently used to identify tumor type and grade is based on tumor histology and specific protein immunohistochemical analysis. 12 Although well established, this approach is labor intensive, time-consuming, expensive, and not always definitive. Immunohistochemistry sometimes produces ambiguous results in distinguishing low-grade astrocytomas from normal brain tissue and is a weak predictor of a patient's response to postoperative therapies or overall survival. 13 As a consequence, alternative methodologies have recently emerged in the tumor diagnostic field. Although these use different technologies (different versions of mass spectrometry 14, 15 and temperature scanning, 5, 6, 8 ), they share a common feature: establishing a global, disease-specific pattern based on disease-specific signatures. These approaches do not allow identification of specific molecular components or pathways that are linked with specific diseases; however, they probe all biopolymers and their complexes in a heterogeneous cellular context, so disease-specific changes have a high probability of being detected if sensitivity is adequate. As soon as a disease-specific pattern is identified, it can be used as a practical diagnostic tool. In this study, we applied temperaturescanning calorimetry to analyze heterogeneous solid brain tumors to obtain patterns (thermograms) specific to different subtypes and grades of gliomas. We show that the thermograms of solid brain tumors could be used as a disease-specific signature that could be used to help identify brain tumor type and grade. These findings suggest a real potential to complement current histological protocols with the DSC analysis to validate diagnostic conclusions.
Heat-induced structural changes measured by DSC represent phase transitions such as melting, unfolding, denaturation, and dissociation of macromolecules. 16 Within complex biological samples, we expect proteins and supramolecular structures to contribute to the observed melting transitions. Major subcellular structures such as nuclei, mitochondria, and cellular membranes FIGURE 2. Four Gaussian curves simultaneously fit to the thermogram of normal brain tissue (temporal lobe). The uppermost solid line is the thermogram, and the dotted line is the sum of the 4 gaussian curves. The lower graph demonstrates the goodness of fit as measured by differences between the experimental points and fitted curves. A w , scaling factor; dH, the change in enthalpy of transition; T m , the temperature at peak maximum. may contribute to the thermogram profile. The results presented here indicate the existence of only 4 distinct group transitions with relatively narrow temperature intervals. Based on these observations, we chose to analyze the experimental thermograms as the sum of 4 two-state transitions. The formal description of a 2-state transition is represented by a gaussian (normal) distribution, so we applied this formalism to approximate the experimental thermograms. As demonstrated in Figure 2 , 4 Gaussian curves give an adequate approximation of a thermogram, which turned out to be a consistent result for all the experimental thermograms obtained. This physical model of the transitions observed has to be applied with a clear understanding of the limitations in the case of complex samples. The parameters of the gaussian distribution, which are normally applied to a reversible transition in a homogeneous material, have to be substituted by apparent values, which reflect the melting or dissociation of large supramolecular structures. Therefore, the values of the enthalpy change and scaling factor must be interpreted in the context of a heterogeneous molecular environment. We anticipate that other analytical approaches may be necessary to obtain more reliable information, and this LGG, low-grade astrocytoma; OLIGO, oligodendroglioma; AW, scaling factor; DH, the change in enthalpy of transition; TM, the temperature at peak maximum.
will be part of future research done by our group. This "apparent" physical model provides more information from experimental data than image analysis or pattern recognition 17 because it allows the potential for identification of transitions that can be attributed to specific cellular structures/components and paves the way to identifying cellular fractions that are major contributors to disease-specific thermogram shifts. 18 Several DSC studies performed on cell cultures, mainly bacterial, have identified multiple transitions that are mapped to the same temperature ranges as observed in our study. 18, 19 These transitions were used to evaluate the thermostability of bacteria and established protein denaturation as the primary cause of thermal death for bacteria, with some strains being more thermostable than others. These results suggest a global response of the proteome to thermal denaturation that is a function of changes in the bacterial proteome among various strains. There was 1 previous attempt to characterize the brain tissue of patients with Alzheimer disease post mortem. 20 The only transition the authors reported was observed at the melting temperature of 90°C. We suggest that this observation was due to denaturation and proteolysis in postmortem samples and/or low sensitivity of the assays (the signals were observed on the millijoule scale vs the microjoule scale in our experiments). Our data suggest that there are specific differences in the intrinsic nature of a given tumor type that are manifested as differences in the thermogram signature. It is plausible to assume that ratios of different subpopulations of tumor cells change with tumor progression. 21 Conservation of the transition temperatures of the 3 transitions observed in all the samples together with quantitative changes in the areas of the peaks argue for the validity of this hypothesis. Interestingly, the fourth transition, which is caused by melting of nucleic acids, does not differentiate between oligodendroglioma and low-grade astrocytoma, but exhibits significant differences between low-grade astrocytomas, oligodendrogliomas, and GBMs. We suggest that the DNA melting transition differences reflect real and significant shifts in the nucleic acid structures during the advanced tumor development.
Although the number of samples in the current study was limited, these results strongly suggest that DSC thermograms have potential clinical application to provide rapid differentiation between tumor grades and normal brain tissue that could be used in conjunction with histological determinations. Thermogram deconvolution with gaussian curves provides 12 quantitative parameters capable of statistically significant differentiation among low-grade astrocytomas, oligodendrogliomas, and highgrade GBMs. This method, if verified in a broader study, may have a significant impact on postoperative examination of brain tumors and, if proven robust, may become a mainstream laboratory technique. The DSC method is relatively inexpensive, requires simple sample processing, and may be completed within 24 hours of surgery. A current limitation of the DSC method is the requirement of at least 500 mg of tissue to obtain unambiguous signals. The current method is therefore not suitable for examination of small samples (ie, biopsy samples); however, removal of some major neutral components, such as erythrocytes and myelin, 22 during sample preparation could enhance the signal-to-noise ratio by an order of magnitude, making the DSC method applicable for analysis of biopsy samples.
CONCLUSION
The long-term goal of this work is to establish a novel approach to determine tumor subtype and eventually to predict tumor response to therapy, progression-free survival, and overall survival of a patient. We envision that this can be done by developing a library of tumor profiles that will be linked to patient responses to a given therapy, progression-free survival, and overall survival. It should be possible to develop a library of standard thermograms that can be used to compare different tumor types, histological grades, and tumors that have received previous treatment. This technology thus has the potential to make unprecedented differentiation between individual tumor characteristics that can allow for personalized therapy for a given patient.
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